Form 4/A for INKT MiNK Therapeutics, Inc.
Accepted 2026-01-14 00:00:00 ET · period of report 2026-01-02 · accession 0001193125-26-012914 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2026-01-14 | 2026-01-02 | INKT | Buell Jennifer | CEO | F - Tax | $11.12 | -10.0K | 57.9K | -15% | -$111.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-02 | F | D | 10,024 | $11.12 | 57,942 | D | — | — | (F1) These shares were withheld for payment of the withholding taxes in relation to the stock issued to the reporting person on January 2, 2026, as previously reported on the Form 4 filed on January 6, 2026 (the "Original Form 4"). The Original Form 4 did not include the shares withheld for payment of withholding taxes in Table I. This amendment is being filed to correct this error. |